MEDS.US DataMEDS AI, Inc.

Healthcare Medical Distribution USA Stocks
0.7439 USD
Close of Nov 15, 2026
0.4925 33.13
Market cap
USD 3.86M
P/E
-
P/B
80.90x
ROE
-
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the current fiscal year annualized from 3 quarters up to Sep 2026.

Is MEDS.US undervalued?

Graham number

The Graham number of DataMEDS AI, Inc. cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

DataMEDS AI, Inc. fundamental analysis

No fundamental analysis for DataMEDS AI, Inc. yet.

DataMEDS AI, Inc. stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About DataMEDS AI, Inc.

DataMEDS AI, Inc. operates as a health IT company in the United States. The company focuses on the vertical integration of technology, pharmacy, pharmaceutical-adjacent, and telemedicine business units to deliver an enhanced healthcare experience for consumers. It offers tools, such as the EinsteinRx, a pharmacy dispensing AI platform; the PharmacyChain, a smart contracts platform; Patient Rx Adherence Tool; and HubRx AI. It also operates as a pharmacy distributor; and provi…

Full company profile